A Study to Evaluate the Safety and Effectiveness of ALKS 2680 in Subjects With Narcolepsy Type 1 (ALKS 2680-201)

Clinical trial NCT06358950 · COMPLETED

Trial details

NCT number: NCT06358950
Sponsor: Alkermes, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Narcolepsy Type 1

Start date: 2024-03-24
Primary completion: 2025-06-19
Enrollment: 92

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.